期刊文献+

肝细胞腺瘤的CT和MRI表现 被引量:15

Imaging manifestation of hepatocellular adenoma on CT and MRI
在线阅读 下载PDF
导出
摘要 目的 探讨肝细胞腺瘤 (HA)的CT和MRI表现。方法 回顾性分析经手术病理证实的 9例HA的影像资料 ,其中CT和MRI扫描各 8例。结果 CT平扫呈等或略低密度影 4/6例 ;CT增强扫描动脉期表现为均匀或不均匀明显高密度影 4/6例 ;门静脉期表现为高密度或略高密度 6/8例 ;3 /5例在延迟期扫描表现为等密度。 2例增强及延迟扫描均为低密度的病灶 ,病理显示其内明显脂肪变。 7/8例在MR的T1WI为均匀或不均匀的高信号影 ,8/8例T2WI表现为均匀或不均匀中高信号影 ;MRI的动态增强扫描与CT增强扫描类似。结论 影像检查能够正确诊断大部分肝脏腺瘤病例 ,MRI对显示HA病理特征优于CT。 Objective To study the imaging features of hepatocellular adenoma(HA) on CT and MRI. Methods Imaging findings of 9 patients with histopathologically proven HA were retrospectively analyzed. Results The mean size of HA was 5 cm (3-12 cm). Four of 6 cases showed iso density or slight hypodensity on plain CT, while homogeneous or heterogeneous hyperdensity on arterial phase in 4/6 cases, hyperdensity or slight hyperdensity on portal venous phase in 6/8 cases, and iso density in 3/5 on delayed phase on CT. Two HA lesions were demonstrated as homogeneous hypodensity on all phases of post contrast scans which were corresponded to the fatty degeneration pathologically. Lesions showed homogeneous or heterogeneous hyperintensity in 7/8 on T1WI, and homogeneous or heterogeneous moderate hyperintensity in 8/8 on T2WI on MRI. Findings on dynamic enhanced MR imaging were similar to the enhance pattern of CT. Conclusion Correct imaging diagnosis is possible in majority of HA. MRI was better than CT on revealing the pathologic features of HA.
出处 《中国医学影像技术》 CSCD 北大核心 2005年第1期80-82,共3页 Chinese Journal of Medical Imaging Technology
关键词 肝肿瘤 肝细胞腺瘤 体层摄影术 X线计算机 磁共振成像 Liver neoplasm Hepatocellular adenoma Tomography X-ray computed Magnetic resonance imaging
  • 相关文献

参考文献12

  • 1刘梅,陈乐真,李向红.肝细胞腺瘤6例(附文献复习)[J].中华肝胆外科杂志,2003,9(3):142-146. 被引量:8
  • 2Grazioli L, Federle MP, Brancatelli G, et al. Hepatic adenomas: imaging and pathologic findings[J]. Radio Graphics, 2001, 21(4):877-894.
  • 3Reddy KR, Joe SBA, Livingstone A, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors and out come[J]. Am Surg, 2001, 67(2):173-178.
  • 4Bawn JK, Holtz F, Bookstein JJ, et al. Possible association between benign hepatomas and oral contraceptives[J]. Lancet, 1973, 2(7835):926-929.
  • 5Reddy KR, Schiff E. Approach to a liver lesion[J]. Semin Liver Dis, 1993, 13(4):423-435.
  • 6Labrune P, Trioche P, Duvaltier I, et al. Hepatocellular adenomas in glycogen storage disease type I and Ⅲ: a series of 43 patients and review of the literature[J]. J Pediatr Gastroenterol Nutr, 1997, 24(3):276-279.
  • 7Terkivatan T, de Wilt JHW, de Man RA, et al. Indications and outcome of treatment for benign hepatic tumors: a critical appraisal[J]. Arch Surg, 2001, 136(9):1033-1038.
  • 8Ichikawa T, Federle MP, Grazioli L, et al. Hepatocellular adenoma: multiphasic CT and pathologic findings in 25 patients[J]. Radiology,2000, 214(3):861-868.
  • 9Molina EG, Schiff ER. Benign solid lesions of the liver. In: Schiff ER, Sorrell MF, Maddrey WC. Schiff's diseases of the liver[M]. 8th ed. Philadelphia: Lippincott-Raven, 1999. 1245-1267.
  • 10Paulson EK, McClellan JS, Washington K, et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings[J]. AJR, 1994, 163(1):113-116.

共引文献7

同被引文献114

引证文献15

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部